Loading…
DarioHealth Corp. is projected to decline to $7.46 by 2027, a -3% move from its current price of $7.70. DRIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.43 | $7.70 | $7.98 | 0.00% |
| May 30 | $7.32 | $7.70 | $8.09 | 0.00% |
| May 31 | $7.24 | $7.70 | $8.19 | -0.01% |
| Jun 1 | $7.17 | $7.70 | $8.26 | -0.01% |
| Jun 2 | $7.11 | $7.70 | $8.33 | -0.01% |
| Jun 3 | $7.06 | $7.70 | $8.40 | -0.01% |
| Jun 4 | $7.01 | $7.70 | $8.45 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.01 | $7.70 | $8.45 | -0.01% |
| Week 2 | $6.74 | $7.70 | $8.79 | -0.03% |
| Week 3 | $6.55 | $7.70 | $9.05 | -0.04% |
| Week 4 | $6.38 | $7.70 | $9.28 | -0.06% |
| Week 5 | $6.24 | $7.69 | $9.48 | -0.07% |
| Week 6 | $6.12 | $7.69 | $9.67 | -0.09% |
| Week 7 | $6.01 | $7.69 | $9.85 | -0.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions.
The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DarioHealth Corp. (DRIO) is a healthcare company in the digital health space with a current price of $7.86 and a market capitalization of $57.48M. Its market rank is 4529.
The forecast shows an evolving price outlook, with the average price in 2026 at $7.86, and a long-term trajectory toward higher values, including a 2030 avg of $10.75 and a 2050 avg of $25.52, with bullish sentiment in several late-2020s and 2030s years.
In 2030 the max is $16.71 and the 30-day view includes a neutral near-term stance, while 2040 points toward higher levels with a max of $24.50 and a 2050 max of $52.85, signaling meaningful long-term upside potential.
Overall, the forecast depicts a path of growth with multiple bullish milestones later in the forecast horizon, tempered by near-term neutrality and cyclical variability.
A major floor 20.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 12.7% above — a clean break opens room to run.
A major ceiling 61.6% above — clearing it would confirm fresh momentum.
Key DRIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.72 | Sell | $7.76 | Sell |
| MA 10 | $8.00 | Sell | $7.86 | Sell |
| MA 20 | $7.90 | Sell | $7.87 | Sell |
| MA 50 | $7.75 | Sell | $8.17 | Sell |
| MA 100 | $9.35 | Sell | $9.06 | Sell |
| MA 200 | $10.61 | Sell | $10.59 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.36 | Neutral |
| Stoch RSI (14) | 16.48 | Buy |
| CCI (20) | -40.32 | Neutral |
| Williams %R (14) | -83.76 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -1.41 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 16.24 | Buy |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 39.65 | Neutral |
| Momentum (10) | -0.98 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 7.50 | Buy |
| ADX (14) | 10.92 | Neutral |
| ATR (14) | 0.27 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 50. The stock is trading near the SMA50 of $7.79, while the SMA200 sits higher at $10.64.
Support is identified at $7.03 and resistance at $8.68, framing a near-term range that aligns with the 30-day high of $9.97 and low of $6.20.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.37 | $7.70 | $9.39 | 0% | Neutral | |
| $5.75 | $7.46 | $10.35 | -3% | Neutral | |
| $5.24 | $7.05 | $10.23 | -8% | Neutral | |
| $6.19 | $8.59 | $12.91 | +12% | Neutral | |
| $7.25 | $10.34 | $15.99 | +34% | Bullish | |
| $6.33 | $9.26 | $14.69 | +20% | Bullish | |
| $6.32 | $9.47 | $15.37 | +23% | Bullish | |
| $6.42 | $9.83 | $16.29 | +28% | Bullish | |
| $5.77 | $9.03 | $15.24 | +17% | Neutral | |
| $6.96 | $11.12 | $19.11 | +44% | Bullish | |
| $7.15 | $12.56 | $23.22 | +63% | Bullish | |
| $11.56 | $24.12 | $49.53 | +213% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.37 | $7.70 | $9.10 | +0.00% |
| June 2026 | $6.68 | $7.89 | $9.59 | +2.52% |
| July 2026 | $6.43 | $7.69 | $9.50 | -2.64% |
| August 2026 | $6.23 | $7.51 | $9.40 | -2.31% |
| September 2026 | $6.37 | $7.74 | $9.79 | +3.07% |
| October 2026 | $6.35 | $7.76 | $9.92 | +0.32% |
| November 2026 | $6.00 | $7.37 | $9.50 | -5.04% |
| December 2026 | $5.85 | $7.23 | $9.39 | -1.94% |
Click any year to see its month-by-month DRIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
DarioHealth Corp.'s 2026 outlook centres on $7.70, within a $6.37 to $9.39 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, DRIO could reach as high as $10.35, with a base case around $7.46 and support toward $5.75 — roughly -3% from $7.70. Price action looks broadly range-bound.
Expect DRIO to range from $5.24 to $10.23 through 2028. The $7.05 average target implies a -8% move from current prices. That is -5% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The DRIO price prediction for 2029 points to an average of $8.59 (low $6.19, high $12.91) — a potential gain of +12% on today's $7.70. Price action looks broadly range-bound.
In 2030, DRIO is projected to trade between $7.25 and $15.99, averaging $10.34 — a potential gain of +34% from today's $7.70. That is up +20% on the projected 2029 average. Buyers look set to stay in control over this stretch.
DarioHealth Corp.'s 2031 outlook centres on $9.26, within a $6.33 to $14.69 range. That is -10% versus the projected 2030 average. That marks a +20% change versus current levels. Momentum favours further upside here.
By 2032, DRIO could reach as high as $15.37, with a base case around $9.47 and support toward $6.32 — roughly +23% from $7.70. Buyers look set to stay in control over this stretch.
Expect DRIO to range from $6.42 to $16.29 through 2033. The $9.83 average target implies a +28% move from current prices. That is up +4% on the projected 2032 average. Momentum favours further upside here.
The DRIO price prediction for 2034 points to an average of $9.03 (low $5.77, high $15.24) — a potential gain of +17% on today's $7.70. A consolidation phase looks the most probable path here.
In 2035, DRIO is projected to trade between $6.96 and $19.11, averaging $11.12 — a potential gain of +44% from today's $7.70. That is up +23% on the projected 2034 average. Momentum favours further upside here.
DarioHealth Corp.'s 2040 outlook centres on $12.56, within a $7.15 to $23.22 range. That is up +13% on the projected 2035 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, DRIO could reach as high as $49.53, with a base case around $24.12 and support toward $11.56 — roughly +213% from $7.70. Momentum favours further upside here.
Investing $1,000 in DRIO today (≈ 129.87013 DRIO) could be worth
$3,132.68
+$2,132.68 (+213%) by 2050 · US Dollar
Based on the average projected DRIO price of $24.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRIOwould be worth at today's price.
$1,000 invested in DRIO on May 27, 2025 (≈ 69.637885 DRIO) would be worth
$536.21
-$463.79 (-46.4%) today · 0.54× · US Dollar
Based on a DRIO entry price of $14.36 vs. today's $7.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8 | $962.5 | -3.7% |
| 1 month ago | $7.42 | $1,037.74 | +3.8% |
| 3 months ago | $11.23 | $685.66 | -31.4% |
| 6 months ago | $11.94 | $644.89 | -35.5% |
| 1 year ago | $14.36 | $536.21 | -46.4% |
| All time (5.0y) ago | $333.6 | $23.08 | -97.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRIO forecast.
Our base-case forecast reaches $15.00 around 2050.
Implied market cap at $15.00: $109.69M
The multi-year outlook shows a shift from near-term neutrality to longer-term bullish momentum. In 2026 the avg is $7.86 with a 0% ROI and NEUTRAL sentiment, followed by 2027 avg $7.63 and 2028 avg $7.28 with negative ROI values, before a notable upswing begins in 2029 with avg $9.03 and ROI 14.9.
From 2030 onward, the forecast indicates stronger upside: 2030 avg $10.75 (ROI 36.8%, BULLISH); 2031 avg $9.55; 2032 avg $9.91; 2033 avg $10.25; 2034 avg $9.35; 2035 avg $11.82 (ROI 50.4%, BULLISH). The trajectory continues to improve toward 2040 with avg $13.16 (ROI 67.4%, BULLISH) and 2040 max $24.50, culminating in 2050 with avg $25.52 (ROI 224.7%, BULLISH) and a max of $52.85.
These are estimates, not guarantees, and the actual path will depend on future developments and market conditions.
Tap a question to reveal the answer.
Avg $10.75, min $7.50, max $16.71; ROI 36.8%; sentiment BULLISH.
The forecast shows bullish sentiment in 2030 (avg $10.75, ROI 36.8%) and in 2050 (avg $25.52, ROI 224.7%), with bullish years also in 2040. Near-term years like 2026-2029 show neutral to modest gains. These are estimates, not guarantees.
Yes—the 2040 forecast has a max of $24.50, with a 2040 avg of $13.16, indicating the potential to surpass $20 within the projection.
Current price $7.86; Market cap $57.48M.
Bullish in 2030, 2031, 2032, 2033, 2035, 2040, and 2050.
DarioHealth Corp. Community Discussion
0Share your DarioHealth Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.